Biosimilars are safe, Australian government tells the public
This article was originally published in SRA
Executive Summary
The Australian Pharmaceutical Benefits Advisory Committee (PBAC) government has issued a statement intended to reassure the public that biosimilar medicines are as safe and effective as their reference drug, in an apparent effort to offset any "misinformation" being disseminated about biosimilars1.